Sales and Marketing

Showing 15 posts of 11527 posts found.

Novartis gets FDA approval for psoriasis drug

January 22, 2015 Sales and Marketing Cosentyx, European Commission, FDA, Novartis, Secukinumab, psoriasis

The US Food and Drug Administration (FDA) has shown Novartis’ skin condition drug Cosentyx the green light to treat patients …

UK makes £30m investment in T-Cell cancer therapy

January 22, 2015 Research and Development, Sales and Marketing Autolus, Cancer, London, T cell, UK, government, oncology, syncona

The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …

EMA launches consultation on clinical trials

January 22, 2015 Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

New chief executive for AiCuris

January 22, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, Holger Zimmermann, Rübsamen-Schaeff

Founded in 2006 as a spin-off from Bayer, AiCuris has found a new chief executive as Helga Rübsamen-Schaeff steps aside …

Olysio and Xarelto boost J&J’s Q4

January 21, 2015 Sales and Marketing J&J, JJ, Janssen, NICE, Remicade, Velcade, Xarelto, financials, hep C, olysio, q4, quarter four

Johnson & Johnson earned a 10% increase in worldwide sales of its drugs in the last quarter of 2014 compared …

Gilead and Strides partner in HIV

January 21, 2015 Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf

Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …

UCB epilepsy drug reaches regulatory bodies

January 21, 2015 Research and Development, Sales and Marketing EMA, FDA, UCB, brivaracetam, epilepsy

UCB has established regulatory milestones for its investigational antiepileptic drug brivaracetam in Europe and the US. The Food and Drug …

BMS names operating officer as new chief executive

January 21, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Giovanni Caforio, Lamberto Andreotti, Yervoy, opdivo

Bristol-Myers Squibb’s chief operating officer Giovanni Caforio will be stepping in to Lamberto Andreotti’s shoes as chief executive from May …

Tauriga Sciences adds venture capitalist

January 21, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hingge Hsu, tauriga sciences

US life sciences firm Tauriga Sciences has appointed Dr Hingge Hsu to its board of directors. Hsu was recently a …

MSF hits out at ‘astronomical’ vaccine prices

January 20, 2015 Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis

Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …

Hospira closing US manufacturing plant

January 20, 2015 Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing

US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …

New vice-chair for Commission on Human Medicines

January 20, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Commission on Human Medicines, angela thomas, chm

Dr Angela Thomas has been appointed as vice-chair of the Commission on Human Medicines (CHM).She replaces Professor Ian Weller who …

Regulators ‘more efficient at approving drugs’

January 19, 2015 Research and Development, Sales and Marketing EMA, EMA), FDA, Health Canada, PMDA)., Pharmaceutical and Medical Devices Agency, Swissmedic, TGA, approvals, cirs, reuters

Global regulatory bodies have become faster at approving new drug products more quickly and consistently, according to a new analysis …

Genentech and Human Longevity ink genomics deal

January 19, 2015 Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity

Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …

Boehringer gains EU approval for Ofev

January 19, 2015 Sales and Marketing Boehringer, Esbriet, IPF, InterMune, ingelheim, nintedanib, ofev

The European Commission has approved Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis (IPF). The approval follows the …
The Gateway to Local Adoption Series

Latest content